Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR5A2 | O00482 | 1/20 | 0.54 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.54 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.53 |
| ▸ | GLRB | P48167 | 1/20 | 0.53 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.46 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | RXRB | P28702 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL132940 | 0.98 | NR5A2 (0.55) | NR5A2NR5A1GLRA3GLRBAKR1C2 | |
| SCHEMBL12477516 | 0.96 | NR5A2 (0.54) | NR5A2NR5A1GLRA3GLRBAKR1C2 | |
| SCHEMBL3854443 | 0.96 | NR5A2 (0.54) | NR5A2NR5A1GLRA3GLRBAKR1C2 | |
| SCHEMBL10864009 | 0.96 | NR5A2 (0.54) | NR5A2NR5A1GLRA3GLRBAKR1C2 | |
| SCHEMBL9019692 | 0.96 | NR5A2 (0.54) | NR5A2NR5A1GLRA3GLRBAKR1C2 | |
| SCHEMBL5164097 | 0.96 | NR5A2 (0.54) | NR5A2NR5A1GLRA3GLRBAKR1C2 | |
| SCHEMBL123001 | 0.96 | NR5A2 (0.54) | NR5A2NR5A1GLRA3GLRBAKR1C2 | |
| SCHEMBL12476701 | 0.96 | NR5A2 (0.54) | NR5A2NR5A1GLRA3GLRBAKR1C2 | |
| SCHEMBL10954587 | 0.96 | NR5A2 (0.54) | NR5A2NR5A1GLRA3GLRBAKR1C2 | |
| SCHEMBL12477683 | 0.96 | NR5A2 (0.54) | NR5A2NR5A1GLRA3GLRBAKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108192419-B | Electronic ink and preparation method thereof | 珠海市益盟环保新材料有限公司 | 2021-01-05 | — | — | CN | claimed |
| US-4535048-A | Toner for development of electrostatic charges | CANON KABUSHIKI KAISHA (JP) | 1985-08-13 | — | — | US | claimed |
| JP-59029259-A | — | — | None | — | — | JP | disclosed |
| US-20260010085-A1 | NON-MAGNETIC ONE-COMPONENT DEVELOPING TONER AND METHOD FOR PRODUCING NON-MAGNETIC ONE-COMPONENT DEVELOPING TONER | KYOCERA DOCUMENT SOLUTIONS INC. (JP) | 2026-01-08 | — | — | US | disclosed |
| US-12405550-B2 | Developing device, process cartridge, and electrophotographic image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2025-09-02 | — | — | US | disclosed |
| CN-109666160-B | Dynamic polymer with hybrid cross-linked network | 厦门天策材料科技有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-115079530-A | Developing device, process cartridge, and electrophotographic image forming apparatus | 佳能株式会社 | 2022-09-20 | — | — | CN | disclosed |
| US-20220291607-A1 | DEVELOPING DEVICE, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2022-09-15 | — | — | US | disclosed |
| EP-4057074-A1 | DEVELOPING DEVICE, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2022-09-14 | — | — | EP | disclosed |
| CN-108192419-B | Electronic ink and preparation method thereof | 珠海市益盟环保新材料有限公司 | 2021-01-05 | — | — | CN | disclosed |
| CN-107698748-B | Dynamic polymer of hybrid cross-linked network and application thereof | 翁秋梅 | 2020-03-10 | — | — | CN | disclosed |
| EP-0513578-A1 | Carrier for electrophotography, two-component type developer for developing electrostatic images, process for producing carrier for electrophotography, and image forming method | CANON KABUSHIKI KAISHA (JP) | 1992-11-19 | — | — | EP | disclosed |
| EP-0482665-A1 | Developer for developing electrostatic image, image forming method, electrophotographic apparatus, apparatus unit, and facsimile apparatus | CANON KABUSHIKI KAISHA (JP) | 1992-04-29 | — | — | EP | disclosed |
| CN-1059410-A | Image forming apparatus, apparatus component and facsimile apparatus | CANON KK (JP) | 1992-03-11 | — | — | CN | disclosed |
| EP-0430076-A2 | Image forming method | CANON KABUSHIKI KAISHA (JP) | 1991-06-05 | — | — | EP | disclosed |
| EP-0427278-A2 | Binder resin and process for producing it | CANON KABUSHIKI KAISHA (JP) | 1991-05-15 | — | — | EP | disclosed |
| US-4626489-A | Process for producing toner for development of electrostatic images by stepwise suspension polymerization | CANON KABUSHIKI KAISHA (JP) | 1986-12-02 | — | — | US | disclosed |
| US-4535048-A | Toner for development of electrostatic charges | CANON KABUSHIKI KAISHA (JP) | 1985-08-13 | — | — | US | disclosed |
| US-4533614-A | BINDER IS LOW MELTING POLYESTER | CANON KABUSHIKI KAISHA (JP) | 1985-08-06 | — | — | US | disclosed |
| JP-S5929259-A | TONER | CANON INC | 1984-02-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260010085-A1 | NON-MAGNETIC ONE-COMPONENT DEVELOPING TONER AND METHOD FOR PRODUCING NON-MAGNETIC ONE-COMPONENT DEVELOPING TONER | PSMD2, PSMD1, SMC4 | NR5A2 2676/4885NR5A1 4069/4885GLRA3 1402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.